期刊文献+

SOCS3在糖尿病小鼠肾小管间质病变中的作用 被引量:8

Role of SOCS3 in tubulointerstitial injury of mice with diabetes
下载PDF
导出
摘要 目的探讨细胞因子信号传导抑制蛋白3(suppressors of cytokine sigmaling,SOCS3)在糖尿病小鼠肾损伤中的作用。方法雄性CD-1小鼠腹腔注射链脲佐菌素(streptozotocin,STZ)诱发糖尿病小鼠模型,成模后8周给予尾静脉快速注射p EFFLAG-I/m SOCS3质粒(1 mg/kg),每隔7天注射1次。成模后12周收集肾皮质,应用透射电镜观察肾小管上皮细胞形态学改变;分别应用RT-PCR和免疫组化法检测CK18和α-SMA mRNA和蛋白的表达;Western blot法检测SOCS3、p-STAT3、CK18和α-SMA的表达。结果与正常对照鼠相比,糖尿病小鼠肾组织中p-STAT3、SOCS3和α-SMA的表达增高,CK18表达降低。SOCS3质粒注射后能下调p-STAT3和α-SMA的表达水平同时上调CK18的表达。结论 SOCS3可能通过抑制信号转导和转录活化因子3(signal transducers and activators of transcription 3,STAT3)的磷酸化从而缓解糖尿病鼠肾小管上皮细胞转分化。 Purpose To investigate the role of SOCS3 on diabetic renal injury. Methods Male CD-1 mice were randomly divided into four groups: control group, diabetic group, empty plasmid vector transfection group and SOCS3 plasmid transfection group. The diabet- ic mice were induced by intraperitoneal injection of STZ at a dose of 150 mg/kg body weight. The mice of transfeetion group were re- ceived an injection of SOCS3 plasmid or empty vector at every 7 clays thereafter. Specimens were collected at 12 week after STZ injec- tion. The morphological changes of tubular epithelial cells were observed by transmission electron microscope. RT-PCR and imnmno- histochemistry were used to determine the mRNA and protein expression of CK18 and α-SMA. Western blotting analysis was used to determine the protein expression of SOCS3, p-STAT3, CK18 and α-SMA. Results SOCS3 overexpression in kidney down-regulated the levels of p-STAT3 and α-SMA but up-regulated the expression of CK18. Conclusion Overexpression of SOCS3 can ameliorate the tubular epithelial-mesenchymal transdifferentiation of diabetic mice via inhibiting the phosphorylation of STAT3.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2015年第8期900-903,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 教育部高等学校博士学科点专项科研基金(新教师类2013132320001)
关键词 糖尿病肾病 肾小管上皮细胞 细胞因子信号传导抑制蛋白3 信号转导和转录活化因子3 diabetic nephropathy tubular epithelial cell SOCS3 STAT3
  • 相关文献

参考文献13

  • 1Retnuzzi G, Schieppati A, Ruggenenti P. Nephropathy in patients with type 2 diabetes[J]. N Engl J Med, 2002,346(15) :1145 - 51.
  • 2Maisonneuve P, Agodoa L, GeUert R, et al. Distribution of pri- mary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand : results from an inter- national comparative study[J]. Am J Kidney Dis, 2000,35 (1) : 157 -65.
  • 3Shi Y, Du C, Zhang Y, et al. Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy[J]. Am J Nephrol, 2010,31 (5) :380 -8.
  • 4Kilpatrick E S, Rigby A S, Atkin S L. For debate. Glucose varia- bility and diabetes complication risk: we need to know the answer [J]. DiabetMed, 2010,27(8) :868 -71.
  • 5Grcevska L, Polenakovi : M. Tubular and interstitial lesions and mononuclear cell infiltz'ation in primary forms of glomerulonephritis [J]. RenFail, 1993,15(4) :485 -93.
  • 6Bani-Hani A H, Campbell M T, Meldrum D R, et al. Cytokines in epithelial-mesenchymal transition : a new insight into obstructive nephropathy[ JOL]. J Urol, 2008,180 (2) :461 - 8.
  • 7Mise K, Hoshino J, Ueno T, et al. Clinical and pathological pre- dictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy [ J/OL ]. Diabetes Metab Res Rev, 2014. doi: 10. 1002/dmrr. 2633. [ Epub ahead of print].
  • 8Habib S L. Alterations in tubular epithelial cells in diabetic ne- phropathy[Jl. J Nephrol, 2013,26(5) : 865 -9.
  • 9Marrero M B, Banes-Berceli A K, Stern D M, Eaton D C. Role of the JAK/STAT signaling pathway in diabetic nephropathy[ J]. Am J Physiol, 2006,290 (4) : F762 - 8.
  • 10Berthier C C, Zhang H, Schin M, et al. Enhanced expression of Janus kinase-signal transducer and activator of transcription path- way members in human diabetic nephropathy [ J ]. Diabetes, 2009,58(2) :469 -77.

二级参考文献9

  • 1张勉之,张敏英,赵松,段建召,张艳秋,左春霞,程项阳,段惠军.Janus激酶抑制剂对高糖诱导的肾小管上皮细胞转分化的作用[J].中国医学科学院学报,2007,29(3):364-369. 被引量:5
  • 2Liu M, Liu Y Z, Feng Y, et al. Novel evidence demonstrates that epithelial-mesenchymal transition contributes to nephrolithiasis-in- duced renal fibrosis[J]. J Surg Res, 2013,182(1 ) :146 -52.
  • 3Tan T K, Zheng G P, Hsu T T, et al. Macrophage matrix metallo- proteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells[ J]. Am J Pathol, 2010,176 (3) :1256 -70.
  • 4Kida Y, Asahina K, Teraoka H, et al. Twist relates to tubular rpithelial-mesenchymal transition and interstitial fibrogenesis in the obstructed kidney [ J ]. J Histochem Cytochem, 2007,55 ( 7 ) : 661 -73.
  • 5Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal tran- sition and chronic allograft tubulointerstitial fibrosis [ J ]. Transplant Rev (Orlando) , 2008,22 ( 1 ) : 1 - 5.
  • 6Burns W C, Thomas M C. The molecular mediators of type 2 epi-thelial to mesenchymal transition (EMT) and their role in renal pathophysiology[ J ]. Expert Rev Mol Med, 2010,12 :e17.
  • 7Nightingale J, Patel S, Suzuki N, et al. Oncostatin M, a cytokine released by activated mononuclear ceils, induces epithelial cell- myofibroblast transdifferentiation via Jak/Stat pathway activation [J]. J Am Soc Nephrol, 2004,15(1) :21 -32.
  • 8Tang S C, Chan L Y, Leung J C, et al. Differential effects of ad- vancedglycation end-products on renal tubular cell inflammation [ J]. Nephrology (Carlton), 2011,16(4) :417 -25.
  • 9石永利,孟凡青.TGF-β1诱导的上皮-间叶转变与肺纤维化[J].临床与实验病理学杂志,2011,27(5):527-530. 被引量:12

共引文献3

同被引文献78

引证文献8

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部